Web1 ago 2024 · JCOG1311 was designed as a randomized phase II/III trial because there were no data on the efficacy and safety of ddTC and ddTC+bevacizumab in cervical … Web29 mar 2024 · The 2024 ASCO Annual Meeting Proceedings – Gynecologic Oncology Abstracts Edition is a listing of all accepted abstracts from the gynecologic oncology track of the 2024 ASCO Annual Meeting. Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO …
A randomized phase II/III trial of conventional paclitaxel and ...
WebA randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Results of the phase II … Web1 ago 2024 · Methods. Patients were randomly assigned to either the cTC or ddTC arm. The cTC regimen was paclitaxel 175 mg/m 2 and carboplatin at an area under the curve (AUC) of 5 on day 1. The ddTC regimen was paclitaxel 80 mg/m 2 on day 1, 8, 15 and carboplatin at AUC of 5 on day 1. Both cTC and ddTC treatments were repeated every 3 weeks for … french country cabinet rack
A randomized phase II/III trial of conventional paclitaxel and ...
Web25 mag 2024 · A randomized phase II/III trial of conventional paclitaxel and carboplatin with/without bevacizumab versus dose-dense paclitaxel and carboplatin with/without … Web23 nov 2024 · Realty Hub. See more homes for sale in. Gulfport. Take a look. 5413 11th Ave S, Gulfport, FL 33707 is a 3 bedroom, 1 bathroom, 900 sqft single-family home built … Web6 lug 2024 · In the phase 3 JCOG0505 study of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in 253 patients in Japan with metastatic or recurrent cervical cancer, median OS was 18.3 versus 17.5 months and median PFS was 6.9 versus 6.2 months, respectively. 9 Similar findings were also observed in the subsequent JCOG1311 study, that … fast fashion - wearing out the planet